Ongoing myocardial damage in patients with heart failure and preserved ejection fraction

Journal of Cardiology

Volumn 60, Issue 6, 2012, Pages 454-461

  Kutsuzawa, Daisuke ^a   Arimoto, Takanori ^a   Watanabe, Tetsu ^a   Shishido, Tetsuro ^a   Miyamoto, Takuya ^a   Miyashita, Takehiko ^a   Takahashi, Hiroki ^a   Niizeki, Takeshi ^a   Takeishi, Yasuchika ^b   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Heart type fatty acid binding protein; Preserved left ventricular systolic function; Troponin T

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; FATTY ACID BINDING PROTEIN; HEART TYPE FATTY ACID BINDING PROTEIN; TROPONIN T; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYZER; ARTICLE; BLOOD SAMPLING; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; CYTOSOL; DEATH; DISEASE COURSE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE INJURY; HEMODYNAMIC PARAMETERS; HOSPITAL READMISSION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; RADIOIMMUNOASSAY; RECEIVER OPERATING CHARACTERISTIC; SUDDEN DEATH; SURVIVAL RATE; SYSTOLE; TISSUE SPECIFICITY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FATTY ACID-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIUM; PROSPECTIVE STUDIES; RISK; STROKE VOLUME; SYSTOLE; TROPONIN T;

EID: 84869088129     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2012.06.006     Document Type: Article

References (27)

1. Satomura H., Wada H., Sakakura K., Kubo N., Ikeda N., Sugawara Y., Ako J., Momomura S. Congestive heart failure in the elderly: comparison between reduced ejection fraction and preserved ejection fraction. J Cardiol 2012, 59:215-219.
2. Goda A., Yamashita T., Suzuki S., Ohtsuka T., Uejima T., Oikawa Y., Yajima J., Koike A., Nagashima K., Kirigaya H., Sagara K., Ogasawara K., Isobe M., Sawada H., Aizawa T. Heart failure with preserved versus reduced left ventricular systolic function: a prospective cohort of Shinken Database 2004-2005. J Cardiol 2010, 55:108-116.
3. Shah R.V., Desai A.S., Givertz M.M. The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis. J Card Fail 2010, 16:260-267.
4. Yamamoto K., Sakata Y., Ohtani T., Takeda Y., Mano T. Heart failure with preserved ejection fraction. Circ J 2009, 73:404-410.
5. Bhatia R.S., Tu J.V., Lee D.S., Austin P.C., Fang J., Haouzi A., Gong Y., Liu P.P. Outcome of heart failure with preserved ejection fraction in a population-based study. New Engl J Med 2006, 355:260-269.
6. Kociol R.D., Horton J.R., Fonarow G.C., Reyes E.M., Shaw L.K., O'Connor C.M., Felker G.M., Hernandez A.F. Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF) linked to Medicare claims. Circ Heart Fail 2011, 4:628-636.
7. Kusumoto A., Miyata M., Kubozono T., Ikeda Y., Shinsato T., Kuwahata S., Fujita S., Takasaki K., Yuasa T., Hamasaki S., Tei C. Highly sensitive cardiac troponin T in heart failure: comparison with echocardiographic parameters and natriuretic peptides. J Cardiol 2012, 59:202-208.
8. Setsuta K., Seino Y., Ogawa T., Arao M., Miyatake Y., Takano T. Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure. Am J Med 2002, 113:717-722.
9. Arimoto T., Takeishi Y., Shiga R., Fukui A., Tachibana H., Nozaki N., Hirono O., Nitobe J., Miyamoto T., Hoit B.D., Kubota I. Prognostic value of elevated circulating heart-type fatty acid binding protein in patients with congestive heart failure. J Card Fail 2005, 11:56-60.
10. Niizeki T., Takeishi Y., Arimoto T., Takahashi T., Okuyama H., Takabatake N., Nozaki N., Hirono O., Tsunoda Y., Shishido T., Takahashi H., Koyama Y., Fukao A., Kubota I. Combination of heart-type fatty acid binding protein and brain natriuretic peptide can reliably risk stratify patients hospitalized for chronic heart failure. Circ J 2005, 69:922-927.
11. Arimoto T., Takeishi Y., Niizeki T., Nozaki N., Hirono O., Watanabe T., Nitobe J., Tsunoda Y., Suzuki S., Koyama Y., Kitahara T., Okada A., Takahashi K., Kubota I. Cardiac sympathetic denervation and ongoing myocardial damage for prognosis in early stages of heart failure. J Card Fail 2007, 13:34-41.
12. Niizeki T., Takeishi Y., Arimoto T., Takabatake N., Nozaki N., Hirono O., Watanabe T., Nitobe J., Harada M., Suzuki S., Koyama Y., Kitahara T., Sasaki T., Kubota I. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients. J Card Fail 2007, 13:120-127.
13. Niizeki T., Takeishi Y., Arimoto T., Nozaki N., Hirono O., Watanabe T., Nitobe J., Miyashita T., Miyamoto T., Koyama Y., Kitahara T., Suzuki S., Sasaki T., Kubota I. Persistently increased serum concentration of heart-type fatty acid-binding protein predicts adverse clinical outcomes in patients with chronic heart failure. Circ J 2008, 72:109-114.
14. Matsuo S., Imai E., Horio M., Yasuda Y., Tomita K., Nitta K., Yamagata K., Tomino Y., Yokoyama H., Hishida A. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009, 53:982-992.
15. Olivetti G., Abbi R., Quaini F., Kajstura J., Cheng W., Nitahara J.A., Quaini E., Di Loreto C., Beltrami C.A., Krajewski S., Reed J.C., Anversa P. Apoptosis in the failing human heart. New Engl J Med 1997, 336:1131-1141.
16. Anversa P., Kajstura J. Myocyte cell death in the diseased heart. Circ Res 1998, 82:1231-1233.
17. Kostin S., Pool L., Elsässer A., Hein S., Drexler H.C., Arnon E., Hayakawa Y., Zimmermann R., Bauer E., Klövekorn W.P., Schaper J. Myocytes die by multiple mechanisms in failing human hearts. Circ Res 2003, 92:715-724.
18. Logeart D., Beyne P., Cusson C., Tokmakova M., Leban M., Guiti C., Bourgoin P., Solal A.C. Evidence of cardiac myolysis in severe nonischemic heart failure and the potential role of increased wall strain. Am Heart J 2001, 141:247-253.
19. Horwich T.B., Patel J., MacLellan W.R., Fonarow G.C. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003, 108:833-838.
20. Sato Y., Yamada T., Taniguchi R., Nagai K., Makiyama T., Okada H., Kataoka K., Ito H., Matsumori A., Sasayama S., Takatsu Y. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 2001, 103:369-374.
21. Meng X., Ming M., Wang E. Heart fatty acid binding protein as a marker for postmortem detection of early myocardial damage. Forensic Sci Int 2006, 160:11-16.
22. Viswanathan K., Kilcullen N., Morrell C., Thistlethwaite S.J., Sivananthan M.U., Hassan T.B., Barth J.H., Hall A.S. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative. J Am Coll Cardiol 2010, 55:2590-2598.
23. Valle R., Aspromonte N., Feola M., Milli M., Canali C., Giovinazzo P., Carbonieri E., Ceci V., Cerisano S., Barro S., Milani L. B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function. J Card Fail 2005, 11:498-503.
24. Grewal J., McKelvie R.S., Persson H., Tait P., Carlsson J., Swedberg K., Ostergren J., Lonn E. Usefulness of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction. Am J Cardiol 2008, 102:733-737.
25. Niizeki T., Takeishi Y., Takabatake N., Shibata Y., Konta T., Kato T., Kawata S., Kubota I. Circulating levels of heart-type fatty acid-binding protein in a general Japanese population: effects of age, gender, and physiologic characteristics. Circ J 2007, 71:1452-1457.
26. Arimoto T., Takeishi Y., Niizeki T., Koyama Y., Okuyama H., Nozaki N., Hirono O., Tsunoda Y., Miyashita T., Shishido T., Okada A., Takahashi K., Kubota I. Ongoing myocardial damage relates to cardiac sympathetic nervous disintegrity in patients with heart failure. Ann Nucl Med 2005, 19:535-540.
27. Tamura H., Watanabe T., Nishiyama S., Sasaki S., Arimoto T., Takahashi H., Shishido T., Miyashita T., Miyamoto T., Nitobe J., Hirono O., Kubota I. Increased left atrial volume index predicts a poor prognosis in patients with heart failure. J Card Fail 2011, 17:210-216.